Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 20 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Danaher Corporation | DHR | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 250.41 | 05:07:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 250.41 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 2 | 20 | - | 182.09 - 269.61 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:29:58 | 10 | $ 248.84 | USD |
Danaher (DHR) Options Flow Summary
Danaher Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 185.23B | 739.70M | - | 23.89B | 4.74B | 6.41 | 39.05 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Danaher News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DHR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 231.16 | 256.72 | 230.74 | 244.47 | 3,930,302 | 19.25 | 8.33% |
| 1 Month | 248.34 | 256.72 | 230.74 | 243.96 | 2,835,410 | 2.07 | 0.83% |
| 3 Months | 239.27 | 259.00 | 230.74 | 248.25 | 2,600,502 | 11.14 | 4.66% |
| 6 Months | 193.50 | 259.00 | 182.09 | 231.07 | 2,861,433 | 56.91 | 29.41% |
| 1 Year | 244.75 | 269.61 | 182.09 | 234.66 | 2,982,969 | 5.66 | 2.31% |
| 3 Years | 260.46 | 333.96 | 182.09 | 259.89 | 2,676,358 | -10.05 | -3.86% |
| 5 Years | 128.76 | 333.96 | 119.60 | 215.51 | 3,082,337 | 121.65 | 94.48% |
Danaher Description
| Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment. |
